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Correspondence 
Urinary Microalbumin as a Marker for 
Intermittent Claudication 
Sir, 
We note with interest he recent paper by Matsushita 
et aI. 1 regarding the use of urinary microalbumin 
excretion as a marker of intermittent claudication and 
wish to comment on several important points. 
Although we are flattered by the eponymous recogni- 
tion of the method of urinary sampling, the authors 
chose to stratify their patients according to the 
absolute albumin-creatinine ratio (ACR) following 
treadmill exercise, rather than using the exercise- 
induced change in ACR from baseline levels. Micro- 
albuminuria is a transient phenomenon in claudica- 
tion, resulting from an increase in glomerular 
permeability following exercise, which reflects a gen- 
eralised increase in vascular permeability. 2 It is well 
documented that ACR increases ignificantly in clau- 
dicants following treadmill exercise with no corre- 
sponding increase in matched control subjects. 3"4 
This study showed that those with an elevated post- 
exercise ACR had a prolonged Doppler ankle pressure 
recovery time (PRT). A significant correlation between 
post-exercise increase in ACR and PRT has previously 
been reported in this journal. 4As one would perhaps 
expect, the authors demonstrated that limiting the 
distance walked to 50% and 25% of the maximum 
exercise tolerance, by repeat esting on different days, 
led to a progressive decrease in the post-exercise ACR. 
This makes the assumption that the pre-exercise ACR 
is reproducible, although no data is given to support 
this. Again, a more valid method would be to assess 
the exercise-induced change in ACR with different 
walking distances. The authors also demonstrated a 
decrease in the absolute post-exercise ACR following 
bypass urgery. No mention was made as to the timing 
of the postoperative sample, which is important as 
microalbuminuria is a consequence of surgery itself as 
well as a marker of postoperative complications. 5 We 
presume that the postoperative assessment was made 
after allowing the inflammatory response following 
surgery to subside. The intermediate-term effect of 
vascular surgical bypass on ACR is also not new. A 
previous study showed that at 3 months following 
bypass urgery for claudication, the baseline ACR was 
unchaged, while the increase in ACR following tread- 
mill exercise was significantly reduced. 6 Matsushita et 
al. conclude that an elevated post-exercise ACR can be 
used to follow the course of the disease but provide no 
longitudinal evidence for this. We believe that urinary 
microalbumin excretion is an important disease 
marker in claudication but suggest hat this study 
does not provide us with any new information. 
P.V. Tisi and C.P. Shearman 
Southampton, U.K. 
P. Gosling 
Birmingham, U.K. 
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No reply received 
Sigmoid pH after Aortoiliac Surgery 
Sir, 
We read with interest he paper on the relationship 
between sigmoidal intramucosal pH and intestinal 
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